Michael Khouw is a 20 year veteran of the financial services industry with broad experience as a strategist, analyst, portfolio manager and proprietary trader of equities, commodities and equity and index derivatives for both buy-side and sell-side firms.
Mike is the co-author of"The Options Edge" (Wiley) a comprehensive guide to understanding the value of options, optionality, volatility and strategy for both retail and institutional investors that includes practical real-life examples of do's and don'ts for everyone from options novices to seasoned practitioners.
Mike was previously a partner at Cantor Fitzgerald and a principal and managing director at CRT Capital. Mike also held senior trader positions at Bluefin Trading, LLC and Gateway Partners, LLC, both Proprietary Trading Firms based in New York, and as an analyst at Ivory Capital, a research-intensive, fundamental value-based investment firm headquartered in Los Angeles.
In his current role as President and Chief Strategist of Optimize Advisors, Mike uses pioneering and proprietary artificial intelligence technology to advise hedge funds, banks, pensions, mutual funds, insurance companies, and family offices in the effective use of listed options for enhancing returns and managing risk.
In addition, Mike shares his insights through articles and frequent speaking engagements at conferences and a broad array of topics including trading strategy, on market structure and regulation.
Mikeis a Former Member of the Philadelphia Stock Exchange, Nasdaq/OMX, NYSE-AMEX,and the New York Mercantile Exchange. Mike holds a B.A. from Tufts University.
Breaking down bearish bets on Ford in the options pit with CNBC contributor Mike Khouw.
Breaking down a bullish bet on Disney in the options pit with CNBC contributor Mike Khouw.
Breaking down bullish bets on Palo Alto in the options pit with CNBC contributor Mike Khouw.
Breaking down a bearish bet on Best Buy in the options pit ahead of earnings with CNBC contributor Mike Khouw.
With Home Depot trading at all-time highs, is it a "buy" ahead of its earnings next week? CNBC contributor Mike Khouw weighs in.